NCT06382558

Brief Summary

Sensorimotor function of the upper limb is often impaired after stroke, even in the chronic phase (minimum 6 months after stroke). Currently, an optimal assessment for sensory processing, one of the most important sensory functions, does not exists. However, our research team has developed a novel assessment paradigm using the KINARM End-Point robot to assess the level of sensory processing of the upper limb. Within a previous study, the investigators examined the validity within 20 chronic stroke patients and 80 age-matched healthy controls by comparing the novel robotic assessment with a set of existing clinical and robotic assessments for the upper limb. The investigators hypothesize that the stroke patients will show a poorer performance on this novel assessment compared to the healthy controls, that the novel assessment will show better correlation coefficients with other sensory tests compared to motor tests, that the novel assessment can differentiate between different motor subgroups of chronic stroke patients, and that the novel assessment shows good test-retest reliability.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
44

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Apr 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 10, 2024

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

April 18, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 24, 2024

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 19, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 19, 2025

Completed
Last Updated

May 15, 2025

Status Verified

May 1, 2025

Enrollment Period

11 months

First QC Date

April 18, 2024

Last Update Submit

May 13, 2025

Conditions

Keywords

StrokeUpper limbSomatosensationSensory processingRobotic assessmentKinematics

Outcome Measures

Primary Outcomes (1)

  • Kinarm: Passive and active discrimination task

    Newly-developed task on the Kinarm End-Point Lab used to assess passive and active sensory processing

    up to 2 days

Secondary Outcomes (13)

  • Kinarm: Arm position matching task

    1 day

  • Kinarm: Visually guided reaching task

    1 day

  • Erasmus modified Nottingham sensory assessment

    1 day

  • Tactile discrimination test

    1 day

  • Tactile functional object recognition

    1 day

  • +8 more secondary outcomes

Study Arms (2)

Chronic stroke patients

Patients who experienced a first unilateral stroke at least 6 months ago

Healthy controls

Healthy subjects with no history of any neurological condition and who are in the same age group as the chronic stroke patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All participants will be recruited from the community sample

You may qualify if:

  • Written informed consent must be obtained prior to any screening procedures
  • First-ever unilateral, supra-tentorial stroke (as defined by WHO)
  • At least 18 years old
  • Being in the chronic phase after stroke (i.e. being at least 6 months after stroke)
  • Motor impairment in the upper limb, defined as Fugl-Meyer score \>22 out of 66 to demonstrate moderate to full upper limb motor function (patients scoring \<23 out of 66 will not be able to comply with the KINARM protocol)

You may not qualify if:

  • Any serious musculoskeletal and/or other neurological disorders
  • Severe communication or cognitive deficits that interfere with the protocol
  • Any disorder, which in the investigator's opinion might jeopardise participant's safety or compliance with the CIP.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

KU Leuven

Leuven, 3001, Belgium

Location

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Geert Verheyden

    KU Leuven

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof. Dr. Geert Verheyden

Study Record Dates

First Submitted

April 18, 2024

First Posted

April 24, 2024

Study Start

April 10, 2024

Primary Completion

March 19, 2025

Study Completion

March 19, 2025

Last Updated

May 15, 2025

Record last verified: 2025-05

Locations